George Washington University Hematology Update Symposium 2024

Description

+ Include: 10 videos + 10 audios, size: 1.27 GB

+ Target Audience: hematologists/oncologists, hospitalists, internal medicine physicians

+ Sample video: contact me for sample video

+ Information:

A concentrated, practice-focused update spanning benign and malignant hematology. Expert-led, case-based lectures translate evolving evidence and guidelines into clear diagnostic and treatment strategies you can apply immediately in clinic, hospital, and infusion settings.

What You Will Learn

• How to streamline workups for anemia, cytopenias, coagulopathies, and thrombophilias

• Evidence-based management of VTE: anticoagulant selection, duration, peri-procedural strategies

• Current standards for leukemia, lymphoma, and myeloma—including frontline, relapsed/refractory, and maintenance approaches

• Transfusion medicine pearls: product selection, thresholds, complications, and stewardship

• Practical updates on targeted agents, immunotherapies, and cellular therapies—and how to manage toxicities

• Supportive care essentials: infection prophylaxis, tumor lysis, TLS/SOS/VOD, and survivorship considerations

Event Details

• Format: Live lectures with case discussions, board-style Q&A, and practical take-home checklists

• Designed for: Rapid implementation in community and academic settings

• Materials: Slide handouts and concise summaries for quick reference

Who Should Attend
Hematologists/oncologists, hospitalists, internal medicine physicians, advanced practice providers, pharmacists, and fellows seeking a high-yield, clinically oriented hematology refresh.

Why Attend

• Convert complex trials and guidelines into simple, usable algorithms

• Update your approach to diagnostics, therapeutics, and toxicity management

• Leave with pragmatic tools to improve quality, safety, and patient outcomes

 

+ Topics:

Saturday, February 17, 2024
TIME	TOPIC	PRESENTER
07:00 AM – 08:00 AM	Breakfast | Visit Exhibit Hall	Exhibitors | Attendees
08:00 AM – 08:15 AM	Welcome | Introduction to Program	Robert S. Siegel, MD Professor of Medicine, Associate Center Director for Education and Training, The George Washington University, GW Cancer Center
08:15 AM – 09:00 AM	Myeloproliferative Neoplasms	Ayalew Tefferi, MD Barbara Woodward Lips Professor of Medicine, Mayo Clinic
09:00 AM – 09:45 AM	Multiple Myeloma	Kenneth Anderson, MD Kraft Family Professor of Medicine Dana-Farber Cancer Institute, Harvard Medical School
09:45 AM – 10:00 AM	Break | Visit Exhibit Hall	Exhibitors | Attendees
10:00 AM – 10:45 AM	Disorders of Coagulation	Kenneth A. Bauer, MD Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center
10:45 AM – 11:30 AM	Acute Myeloid Leukemia	Samah Nassereddine, MD Assistant Professor of Medicine, The George Washington University, GW Cancer Center
11:30 AM – 12:15 PM	Bone Marrow Failure Syndromes, PNH, and MDS	Amy DeZern, MD, MHS Associate Professor The Johns Hopkins University School of Medicine
12:15 PM – 01:15 PM	Lunch | Visit Exhibit Hall	Exhibitors | Attendees
12:15 PM – 01:15 PM	Lunch Product Forum sponsored by Pfizer	Speaker- TBC
01:15 PM – 02:00 PM	Chronic Lymphocytic Leukemia	Imad A. Tabbara, MD Chief, Division of Hematology/Oncology of DeCesaris Cancer Institute, Anne Arundel Medical Center, Clinical Professor of Medicine, The George Washington University
02:00 PM – 02:45 PM	Lymphoma	Nina Delaney Wagner-Johnston, MD Director of Lymphoma Drug Development, The Sidney Kimmel Comprehensive Cancer Center, Professor of Oncology, The Johns Hopkins University School of Medicine
02:45 PM – 03:30 PM	Cellular Therapies	Catherine Bollard, MBChB, MD, FRACP, FRCPA Professor of Pediatrics, Director, Center for Cancer and Immunology Research, Children’s National Hospital and The George Washington University
03:30 PM – 03:35 PM	Closing Remarks | Adjournment	Robert S. Siegel, MD Professor of Medicine, Associate Center Director for Education and Training, The George Washington University, GW Cancer Center